A substantial advancement in glucose management is emerging with the approval of tirzepatide in a 45mg form. This updated formulation builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, and https://majayrlm223134.blog5.net/91858537/significant-introduction-tirzepatide-45mg-for-blood-sugar-control